← Back
Data updated: Mar 10, 2026
CURRAX
NeurologyMetabolic
CURRAX is a specialty pharmaceutical company focused on Neurology, Metabolic. Key products include ONZETRA XSAIL.
2008
Since
3
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 91%
1 drugs Phase 3: 1
Metabolic 9%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2008-04-15
- Latest
- 2024-11-21
- Applications
- 3